Clearmind Medicine Stock Scheduled to Reverse Split on Monday, October 5th (NASDAQ:CMND)

by · The Markets Daily

Clearmind Medicine Inc. (NASDAQ:CMND – Free Report) shares are scheduled to reverse split before the market opens on Monday, October 5th. The 1-8 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the market closes on Sunday, October 4th.

Clearmind Medicine Price Performance

Shares of CMND stock traded down $0.09 during trading on Thursday, hitting $0.72. The company had a trading volume of 219,393 shares, compared to its average volume of 965,167. The firm has a market capitalization of $730,116.00, a P/E ratio of -0.02 and a beta of 0.81. Clearmind Medicine has a one year low of $0.71 and a one year high of $480.00. The company has a debt-to-equity ratio of 0.01, a quick ratio of 4.31 and a current ratio of 4.31. The stock’s 50-day moving average price is $1.41 and its 200 day moving average price is $3.93.

Clearmind Medicine (NASDAQ:CMND – Get Free Report) last posted its quarterly earnings data on Thursday, September 10th. The company reported ($0.57) EPS for the quarter.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen upgraded Clearmind Medicine from a “strong sell” rating to a “sell” rating in a research note on Saturday, June 20th.

Read Our Latest Stock Analysis on CMND

Clearmind Medicine Company Profile

(Get Free Report)

Clearmind Medicine Inc is a biotechnology company focused on developing psychedelic-derived therapeutics for behavioral and mental health disorders. Its research programs are designed to address conditions with significant unmet medical needs, including alcohol use disorder and binge-related behaviors.

The company’s pipeline includes investigational compounds based on novel psychedelic molecules, including 5-methoxy-2-aminoindane (MEAI). Clearmind is studying these compounds for their potential to reduce harmful consumption patterns and support improved mental health outcomes.

Featured Stories